atopic-dermatitis

Documents about atopic-dermatitis

• A Clinical Study to Evaluate SM17 in Healthy Participants#840608ClinicalTrials.gov
• The Effect of Isosorbide Diesters Based Moisturizer on Skin Health#875882ClinicalTrials.gov
• 228 The prevalence of eczema beyond childhood: A systematic review and meta-analysis of longitudinal studies#614701eScholarship
• Minimal Disease Activity as a Therapeutic Goal in Atopic Dermatitis: Predictive Factors of Sustainability in a Multicenter Cohort.#822NCBI PubMed Central
• Development of IgE autoantibodies in newborns with atopic dermatitis (DIANA): protocol of a prospective, non-interventional, observational birth cohort.#251109NCBI PubMed Central
• Why physicians underuse patient-reported outcomes in atopic dermatitis and chronic urticaria - Insights from the UCARE/ADCARE PROMUSE study.#281180NCBI PubMed Central
• MDI1228, a topical pan-JAK inhibitor, disrupts dermal fibroblast-T cell chemokine crosstalk to resolve allergic contact and atopic dermatitis.#427733NCBI PubMed Central
• Variations in Healthcare Provider Interactions and Treatment Satisfaction by Patient Race and Ethnicity: A Survey of Adults with Atopic Dermatitis.#483449NCBI PubMed Central
• Skin-mind connection in atopic dermatitis: Associations of disease severity with skin barrier function, stress, anxiety, and quality of life.#685427NCBI PubMed Central
• A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants#854578ClinicalTrials.gov
• Therapist-guided vs Self-guided CBT for AD: Non-inferiority Trial#883583ClinicalTrials.gov
• Remote Interdisciplinary Care for Atopic Dermatitis Using a Digital Care Concept (ADCompanion): Protocol for a Multicenter Randomized Trial#965861Bielefeld Pub
• The Prevalence and Effects of Gestational Maternal Allergy: A Narrative Review#215024DigitalCommons@WayneState
• Real-world effectiveness and safety of tralokinumab in moderate-to-severe atopic dermatitis with malignancy, chronic infections, and multimorbidity.#297288NCBI PubMed Central
• The Role of Inflammatory Biomarkers in Disease Severity and Treatment Response across Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa-A Narrative Review.#297329NCBI PubMed Central
• The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease#803612ClinicalTrials.gov
• Probiotics and Allergic Diseases#865028ClinicalTrials.gov
• Effect of Pimecrolimus Cream on Cathelicidin Levels in Subjects With Eczema#874330ClinicalTrials.gov
• Upadacitinib for Atopic Dermatitis Involving Special and Sensitive Areas: Real-World Multicenter Outcomes in Hand, Head/Neck, and Genital Involvement.#823NCBI PubMed Central
• Clinical Outcomes Following Personalized Gut Microbiota-Targeted Therapy in Children with Atopic Dermatitis and Laboratory-Confirmed Dysbiosis: A Single-Arm Prospective Pilot Study.#455309NCBI PubMed Central
• Hyper-IgE syndromes in pediatrics: clinical spectrum, differential diagnosis, and management#481481ARPHA OAI-PMH Endpoint
• Effect of EMD Protocol for Urge on Dermatology-specific Quality of Life#859530ClinicalTrials.gov
• Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy#872842ClinicalTrials.gov
• Evaluation of TLL-018 Extended and Immediate Release Formulation for Bioequivalence Testing in Healthy Chinese Subjects#879287ClinicalTrials.gov
• NiPPeR Randomised Trial - Child Follow Up Study#994406ClinicalTrials.gov
• Evidence for the absence of attentional biases towards stigma- and disease-related information in Atopic Dermatitis (preprint)#158337OSF
• An Overview of the Skin Microbiome, the Potential for Pathogen Shift, and Dysbiosis in Common Skin Pathologies#352104ResearchOnline@ND
• Maternal-prenatal gut microbiome-systemic metabolome perturbations and TH2-skewed immunity link to offspring gut microbiome disruption and atopic dermatitis susceptibility#375088ScholarBank@NUS
• A Study of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic Dermatitis#900791ClinicalTrials.gov
• The potential of targeted IL-4 therapy for the comorbidity of atopic dermatitis and attention-deficit/hyperactivity disorder in children via the skin-brain axis.#402458NCBI PubMed Central
• Allergy and Immunology Natural History Study#897800ClinicalTrials.gov
• Assessment of the Impact of Whole Body Cryostimulation on Skin Physiological Indicators#912498ClinicalTrials.gov
• Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic#1046244ClinicalTrials.gov
• Multiplex Specific IgE Profiling in Neonatal Stool of Preterms Predicts IgE-Mediated Disease#178096HAL (France)
• SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)#245376ClinicalTrials.gov
• Discovery of A <i>SLAMF1</i> Gene Change That Increases Dogs' Risk of Developing Canine Atopic Dermatitis: a Plain Language Summary#273461Europe PMC
• Relationships Among Inflammation, Physical and Mental Health in Subjects With Chronic Inflammatory Physical Diseases.#387247ClinicalTrials.gov
• A bioinformatic single-cell and structure-informed framework identifies a baicalin–CA2–keratinocyte state axis in atopic dermatitis#686602PLOS
• Determinants of Chronic Inflammatory Skin Disease Trajectories#881977ClinicalTrials.gov
• The Importance of Achieving High Treatment Targets in Atopic Dermatitis: A Narrative Review#299100Springer Nature OA
• Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)#825602ClinicalTrials.gov
• Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route#882211ClinicalTrials.gov
• A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection#913929ClinicalTrials.gov
• Nationwide Research on the Rewilding of Kindergarten Yards#813507ClinicalTrials.gov
• A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)#841919ClinicalTrials.gov
• Itch Relief and Quality-of-Life Improvement with Abrocitinib and Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE COMPARE and JADE DARE.#380622NCBI PubMed Central
• Expanded Access to Upadacitinib#825033ClinicalTrials.gov
• The Effects of an Oral Prebiotic and an Oral Synbiotic Supplement in Combination With a Topical Lotion and Soap On Eczema#903209ClinicalTrials.gov
• The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.#864135ClinicalTrials.gov
• Achieving minimal disease activity in atopic dermatitis is associated with fewer flares, reduced healthcare resource utilization, and improved disease control: analysis from the real-world MEASURE-AD study#1015167Deutsche Nationalbibliothek